(Q36179528)

12 August 2017

1 reference

title

Role of metabolism in drug-induced idiosyncratic hepatotoxicity (English)

1 reference

12 August 2017

1 reference

1 reference

Jennie L Walgren

1

1 reference

12 August 2017

Michael D Mitchell

series ordinal

2

1 reference

12 August 2017

David C Thompson

series ordinal

3

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

Critical Reviews in Toxicology

12 August 2017

published in

1 reference

12 August 2017

volume

35

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

325-361

1 reference

Ticlopidine-associated cholestatic hepatitis

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Acute liver injury associated with the use of ebrotidine, a new H2-receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Hepatic veno-occlusive disease due to DTIC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Metabolic activation of valproic acid and drug-mediated hepatotoxicity. Role of the terminal olefin, 2-n-propyl-4-pentenoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Hepatotoxicity in drug development: detection, significance and solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Disulfiram-induced hepatitis. Report of two cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

The safety profile of the fluoroquinolones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Diclofenac-associated hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Temafloxacin syndrome: review of 95 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Xenobiotic acyl glucuronides and acyl CoA thioesters as protein-reactive metabolites with the potential to cause idiosyncratic drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Idiosyncratic liver toxicity of nonsteroidal antiinflammatory drugs: molecular mechanisms and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Implication of Rifampicin-quinone in the Irreversible Binding of Rifampicin to Macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

The influence of 4-alkyl substituents on the formation and reactivity of 2-methoxy-quinone methides: evidence that extended pi-conjugation dramatically stabilizes the quinone methide formed from eugenol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Severe cholestatic hepatitis caused by thiazolidinediones: risks associated with substituting rosiglitazone for troglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Carbonyl reduction of naltrexone and dolasetron by oxidoreductases isolated from human liver cytosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Underlying endotoxemia augments toxic responses to chlorpromazine: is there a relationship to drug idiosyncrasy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Severe hepatic failure related to nevirapine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Drug-protein conjugates--XVIII. Detection of antibodies towards the antimalarial amodiaquine and its quinone imine metabolite in man and the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Labetalol hepatotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Urinary Metabolites of Halothane in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil in human liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

The chemistry, toxicology, and identification in rat and human urine of 4-hydroxy-5-phenyl-1,3-oxazaperhydroin-2-one: a reactive metabolite in felbamate bioactivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Mechanisms of idiosyncratic drug reactions: the case of felbamate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Valproic acid hepatic fatalities: a retrospective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Comparative pharmacokinetic profile of two imidazopyridine drugs: zolpidem and alpidem

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Expression of autoantibodies to specific cytochromes P450 in a case of disulfiram hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

The safety of newly approved medicines: do recent market removals mean there is a problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Lessons from the glitazones: a story of drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Concurrent inflammation as a determinant of susceptibility to toxicity from xenobiotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Hepatotoxicity associated with the new antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Acute liver injury related to the use of niperotidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Cholestatic jaundice, an unusual side effect of etretinate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Metabolic activation of the tricyclic antidepressant amineptine by human liver cytochrome P-450.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Mylotarg (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Comparative toxicological study on the hepatic safety of entacapone and tolcapone in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Effects of entacapone and tolcapone on mitochondrial membrane potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

The mechanism of bioactivation and antigen formation of amodiaquine in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

In vitro and in vivo inhibition of rat liver aldehyde dehydrogenase by s-methyl N, N-diethylthiolcarbamate sulfoxide, a new metabolite of disulfiram

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Troglitazone quinone formation catalyzed by human and rat CYP3A: an atypical CYP oxidation reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Hepatotoxicity of clozapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Identification of a reactive metabolite of terbinafine: insights into terbinafine-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

The deuterium isotope effect for the alpha-hydroxylation of tamoxifen by rat liver microsomes accounts for the reduced genotoxicity of [D5-ethyl]tamoxifen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Toremifene metabolism in rat, mouse and human liver microsomes: identification of alpha-hydroxytoremifene by LC-MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Metabolism and excretion of tolcapone, a novel inhibitor of catechol-O-methyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

In vitro metabolism of 2-acetylbenzothiophene: relevance to zileuton hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Mechanism of idiosyncratic drug reactions: reactive metabolite formation, protein binding and the regulation of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Bioactivation of the nontricyclic antidepressant nefazodone to a reactive quinone-imine species in human liver microsomes and recombinant cytochrome P450 3A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Reactivity of atropaldehyde, a felbamate metabolite in human liver tissue in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Metabolic activation of unsaturated derivatives of valproic acid. Identification of novel glutathione adducts formed through coenzyme A-dependent and -independent processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

In vitro metabolism of acitretin by human liver microsomes: evidence of an acitretinoyl-coenzyme A thioester conjugate in the transesterification to etretinate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Electrospray ionization mass spectrometric analysis of intact cytochrome P450: identification of tienilic acid adducts to P450 2C9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Severe cholestatic hepatitis in a patient taking acitretin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Diclofenac covalent protein binding is dependent on acyl glucuronide formation and is inversely related to P450-mediated acute cell injury in cultured rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Hepatic reactions associated with ketoconazole in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Timing of new black box warnings and withdrawals for prescription medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Fialuridine and its metabolites inhibit DNA polymerase gamma at sites of multiple adjacent analog incorporation, decrease mtDNA abundance, and cause mitochondrial structural defects in cultured hepatoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

A review of the common properties of drugs with idiosyncratic hepatotoxicity and the "multiple determinant hypothesis" for the manifestation of idiosyncratic drug toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Overview--in vitro inhibition of aldehyde dehydrogenase by disulfiram and metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Differential in vitro hepatotoxicity of troglitazone and rosiglitazone among cryopreserved human hepatocytes from 37 donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Thiophene derivatives as new mechanism-based inhibitors of cytochromes P-450: inactivation of yeast-expressed human liver cytochrome P-450 2C9 by tienilic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Thiols alter the partitioning of calicheamicin-induced deoxyribose 4'-oxidation reactions in the absence of DNA radical repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Trovafloxacin-induced acute hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Ranitidine treatment during a modest inflammatory response precipitates idiosyncrasy-like liver injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Fatal acute fulminant liver failure due to clozapine: a case report and review of clozapine-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Differential selectivity in carbamazepine-induced inactivation of cytochrome P450 enzymes in rat and human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Tolerance, danger, and the extended family

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Inhibition of recombinant human mitochondrial aldehyde dehydrogenase by two intermediate metabolites of disulfiram

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Impaired oxidation of debrisoquine in patients with perhexiline liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Isoniazid and Iproniazid: Activation of Metabolites to Toxic Intermediates in Man and Rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Antibody mediated hepatocyte injury in methyl dopa induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Entacapone, a novel catechol-O-methyltransferase inhibitor for Parkinson's disease, does not impair mitochondrial energy production

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Metabolic disposition of 14C-bromfenac in healthy male volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Perhexiline maleate-induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Dihydralazine hepatitis: report of a case and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Advances in molecular toxicology-towards understanding idiosyncratic drug toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Genetic susceptibility to adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Biotransformations of glafenine in the rat and in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Jaundice and hepatocellular damage associated with nevirapine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Immunochemical detection of liver protein adducts of the nonsteroidal antiinflammatory drug diclofenac

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Covalent binding of xenobiotics to specific proteins in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Structural requirements for bioactivation of anticonvulsants to cytotoxic metabolites in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Comparison of ketoconazole- and fluconazole-induced hepatotoxicity in a primary culture system of rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

N-deacetyl ketoconazole-induced hepatotoxicity in a primary culture system of rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Interaction between human serum albumin and the felbamate metabolites 4-Hydroxy-5-phenyl-[1,3]oxazinan-2-one and 2-phenylpropenal

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Effect of troglitazone on cytochrome P450 enzymes in primary cultures of human and rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Determination of in vivo adducts of disulfiram with mitochondrial aldehyde dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Combined glutathione-S-transferase M1 and T1 genetic polymorphism and tacrine hepatotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

In vitro metabolism of tolcapone to reactive intermediates: relevance to tolcapone liver toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

The effect of enzyme inhibition on the metabolism and activation of tacrine by human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Hepatic adverse reactions associated with nefazodone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Biotransformation of diclofenac sodium (Voltaren) in animals and in man. I. Isolation and identification of principal metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Fluoride metabolites after prolonged exposure of volunteers and patients to desflurane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Fluorinated analogues as mechanistic probes in valproic acid hepatotoxicity: hepatic microvesicular steatosis and glutathione status

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Enzyme-induction dependent bioactivation of troglitazone and troglitazone quinone in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Synthesis and in vitro reactivity of 3-carbamoyl-2-phenylpropionaldehyde and 2-phenylpropenal: putative reactive metabolites of felbamate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Identification of modified atropaldehyde mercapturic acids in rat and human urine after felbamate administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Toxic effect of troglitazone on cultured rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Human UDP-glucuronosyltransferases: metabolism, expression, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

New concepts in immunology relevant to idiosyncratic drug reactions: the "danger hypothesis" and innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Formation of trifluoroacetylated protein antigens in cultured rat hepatocytes exposed to halothane in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Nefazodone, meta-chlorophenylpiperazine, and their metabolites in vitro: cytochromes mediating transformation, and P450-3A4 inhibitory actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Tamoxifen: is it safe? Comparison of activation and detoxication mechanisms in rodents and in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Covalent binding of carbamazepine reactive metabolites to P450 isoforms present in the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Formation of a novel quinone epoxide metabolite of troglitazone with cytotoxicity to HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Disulfiram metabolism as a requirement for the inhibition of rat liver mitochondrial low Km aldehyde dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Identification of a S-hexahydro-1H-azepine-1-carbonyl adduct produced by molinate on rat hemoglobin beta(2) and beta(3) chains in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

CINCHOPHEN—IS THERE A SAFE METHOD OF ADMINISTRATION?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Role of Drug Disposition in Drug Hypersensitivity: A Chemical, Molecular, and Clinical Perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

An investigation of the formation of cytotoxic, protein-reactive and stable metabolites from carbamazepine in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

21 January 2018

Flutamide Hepatotoxicity

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Opposite Behaviors of Reactive Metabolites of Tienilic Acid and Its Isomer toward Liver Proteins: Use of Specific Anti-Tienilic Acid−Protein Adduct Antibodies and the Possible Relationship with Different Hepatotoxic Effects of the Two Compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Oxidation of Tienilic Acid by Human Yeast-Expressed Cytochromes P-450 2C8, 2C9, 2C18 and 2C19. Evidence that this Drug is A Mechanism-Based Inhibitor Specific for Cytochrome P-450 2C9

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Human Anti-Mitochondria Autoantibodies Appearing in Iproniazid-Induced Immunoallergic Hepatitis Recognize Human Liver Monoamine Oxidase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

Induction of hepatic cytochrome P-450c-dependent monooxygenase activities by dantrolene in rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440590935620

10.1080/10408440590935620

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference